Opportunity ID: 310598

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-19-077
Funding Opportunity Title: Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 26, 2018
Last Updated Date: Dec 01, 2021
Original Closing Date for Applications: Jan 07, 2022
Current Closing Date for Applications: Dec 02, 2021
Archive Date: Jan 01, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public housing authorities/Indian housing authorities
County governments
State governments
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this Funding Opportunity Announcement (FOA) is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-19-077.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Expired as per NOT-AI-22-009 Dec 01, 2021
Nov 26, 2018

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-19-077
Funding Opportunity Title: Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 26, 2018
Last Updated Date: Dec 01, 2021
Original Closing Date for Applications: Jan 07, 2022
Current Closing Date for Applications: Dec 02, 2021
Archive Date: Jan 01, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public housing authorities/Indian housing authorities
County governments
State governments
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this Funding Opportunity Announcement (FOA) is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-19-077.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-19-077
Funding Opportunity Title: Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 26, 2018
Last Updated Date: Nov 26, 2018
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 07, 2022
Archive Date: Feb 12, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
County governments
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-19-077.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00246485 Jan 05, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00259234 Jan 05, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269663 Oct 28, 2021 Dec 02, 2021 View

Package 1

Mandatory forms

310598 RR_SF424_2_0-2.0.pdf

310598 PHS398_CoverPageSupplement_4_0-4.0.pdf

310598 RR_OtherProjectInfo_1_4-1.4.pdf

310598 PerformanceSite_2_0-2.0.pdf

310598 RR_KeyPersonExpanded_2_0-2.0.pdf

310598 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

310598 RR_Budget_1_4-1.4.pdf

310598 RR_SubawardBudget30_1_4-1.4.pdf

310598 PHS398_ModularBudget_1_2-1.2.pdf

310598 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

310598 RR_SF424_2_0-2.0.pdf

310598 PHS398_CoverPageSupplement_5_0-5.0.pdf

310598 RR_OtherProjectInfo_1_4-1.4.pdf

310598 PerformanceSite_2_0-2.0.pdf

310598 RR_KeyPersonExpanded_2_0-2.0.pdf

310598 PHS398_ResearchPlan_4_0-4.0.pdf

310598 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

310598 RR_Budget_1_4-1.4.pdf

310598 RR_SubawardBudget30_1_4-1.4.pdf

310598 PHS398_ModularBudget_1_2-1.2.pdf

310598 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

310598 RR_SF424_5_0-5.0.pdf

310598 PHS398_CoverPageSupplement_5_0-5.0.pdf

310598 RR_OtherProjectInfo_1_4-1.4.pdf

310598 PerformanceSite_4_0-4.0.pdf

310598 RR_KeyPersonExpanded_4_0-4.0.pdf

310598 PHS398_ResearchPlan_4_0-4.0.pdf

310598 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

310598 RR_Budget_3_0-3.0.pdf

310598 RR_SubawardBudget30_3_0-3.0.pdf

310598 PHS398_ModularBudget_1_2-1.2.pdf

310598 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T09:41:50-05:00

Share This Post, Choose Your Platform!

About the Author: